Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study

NCT03234686 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.

NCT NCT03234686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03234686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deferiprone to Delay Dementia (The 3D Study): a Clinical Proof of Concept Study
Lead sponsor
Neuroscience Trials Australia
Phase
Phase 2
Overall status
Completed
Start date
January 19, 2018
Completion date
February 23, 2023
Enrollment
81 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

mild alzheimer's disease, mild cognitive impairment, prodromal alzheimer's disease